Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-04-22 12:53 Tx date 2022-04-18 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Warrants
37 - Stock split or consolidation
|
-9,000,000 vol |
3,000,000 | |
Filed 2022-04-22 12:52 Tx date 2022-04-18 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Indirect Ownership)
|
Warrants
37 - Stock split or consolidation
|
-3,187,500 vol |
1,062,500 | |
Filed 2022-04-22 12:52 Tx date 2022-04-18 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-4,537,500 vol |
1,512,500 | |
Filed 2022-04-22 12:51 Tx date 2022-04-18 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-600,000 vol |
200,000 | |
Filed 2022-04-22 12:49 Tx date 2022-04-18 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-5,490,000 vol |
1,830,000 | |
Filed 2022-04-22 12:49 Tx date 2022-04-18 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-3,139,500 vol |
1,046,500 | |
Filed 2022-04-22 12:48 Tx date 2022-04-18 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-4,537,500 vol |
1,512,500 | |
Filed 2021-05-13 15:52 Tx date 2021-05-12 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,400
-40,000 vol $0.16 each |
4,186,000 | |
Filed 2021-05-13 15:51 Tx date 2021-05-12 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,080
-24,000 vol $0.17 each |
4,226,000 | |
Filed 2021-05-11 16:35 Tx date 2021-05-11 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,800
-40,000 vol $0.17 each |
7,320,000 | |
Filed 2021-05-06 12:35 Tx date 2021-05-05 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,600
-40,000 vol $0.19 each |
7,360,000 | |
Filed 2021-05-03 17:55 Tx date 2021-05-03 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,970
-34,000 vol $0.205 each |
7,400,000 | |
Filed 2021-04-30 18:56 Tx date 2021-04-30 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,585
-37,000 vol $0.205 each |
7,434,000 | |
Filed 2021-04-30 18:55 Tx date 2021-04-28 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,890
-9,000 vol $0.21 each |
7,471,000 | |
Filed 2021-04-26 16:38 Tx date 2021-04-26 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,500
-100,000 vol $0.225 each |
7,480,000 | |
Filed 2021-04-07 17:11 Tx date 2021-04-07 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,800
-20,000 vol $0.24 each |
7,580,000 | |
Filed 2021-04-06 16:53 Tx date 2021-04-06 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,800
-60,000 vol $0.23 each |
7,600,000 | |
Filed 2021-04-06 16:52 Tx date 2021-04-05 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,387.50
-82,500 vol $0.235 each |
7,660,000 | |
Filed 2021-04-06 16:51 Tx date 2021-04-01 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,880
-8,000 vol $0.235 each |
7,742,500 | |
Filed 2021-02-17 18:01 Tx date 2021-02-16 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,355
-49,500 vol $0.29 each |
7,750,500 | |
Filed 2021-02-02 19:57 Tx date 2021-02-02 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,880
-149,500 vol $0.24 each |
7,800,000 | |
Filed 2021-02-02 19:56 Tx date 2021-02-02 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,940
-12,000 vol $0.245 each |
7,949,500 | |
Filed 2021-02-02 19:55 Tx date 2021-02-02 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,625
-38,500 vol $0.25 each |
7,961,500 | |
Filed 2021-01-21 18:54 Tx date 2020-12-30 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Control or Direction)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$425,000
+4,250,000 vol $0.10 each |
4,250,000 | |
Filed 2021-01-21 18:52 Tx date 2020-12-09 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-01-21 18:50 Tx date 2020-12-30 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$425,000
+4,250,000 vol $0.10 each |
4,250,000 | |
Filed 2021-01-21 18:47 Tx date 2020-12-09 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Emma Jane Sander Panenka (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-01-12 18:32 Tx date 2020-12-30 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$205,000
+2,050,000 vol $0.10 each |
6,050,000 | |
Filed 2021-01-12 18:30 Tx date 2020-12-30 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$205,000
+2,050,000 vol $0.10 each |
6,050,000 | |
Filed 2020-12-18 23:16 Tx date 2020-12-09 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
12,000,000 | ||
Filed 2020-12-18 23:16 Tx date 2020-12-09 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Holder: Translational Life Sciences Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,000,000 | ||
Filed 2020-12-18 23:15 Tx date 2020-12-09 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
800,000 | ||
Filed 2020-12-18 23:15 Tx date 2020-12-09 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
4,000,000 | ||
Filed 2020-12-18 23:14 Tx date 2020-12-09 |
$NEON
NeonMind Biosciences Inc. |
Panenka, William
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,000,000 | ||
Filed 2018-01-22 Tx date 2018-01-19 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-53,100
-90,000 vol $0.59 each |
476,500 | |
Filed 2018-01-22 Tx date 2018-01-18 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-53,100
-90,000 vol $0.59 each |
566,500 | |
Filed 2018-01-18 Tx date 2018-01-16 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-43,771
-65,000 vol $0.67 each |
681,500 | |
Filed 2018-01-18 Tx date 2018-01-16 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,750
-25,000 vol $0.67 each |
656,500 | |
Filed 2018-01-16 Tx date 2018-01-11 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,300
-30,000 vol $0.61 each |
1,016,500 | |
Filed 2018-01-16 Tx date 2018-01-15 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-53,100
-90,000 vol $0.59 each |
746,500 | |
Filed 2018-01-16 Tx date 2018-01-12 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-47,700
-90,000 vol $0.53 each |
836,500 | |
Filed 2018-01-16 Tx date 2018-01-12 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,042
-90,000 vol $0.53 each |
926,500 | |
Filed 2018-01-16 Tx date 2018-01-11 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-36,000
-60,000 vol $0.60 each |
1,046,500 | |
Filed 2018-01-08 Tx date 2018-01-05 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-57,652.65
-85,500 vol $0.67 each |
1,111,000 | |
Filed 2018-01-08 Tx date 2018-01-05 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,060
-4,500 vol $0.68 each |
1,106,500 | |
Filed 2018-01-08 Tx date 2018-01-04 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-64,800
-90,000 vol $0.72 each |
1,196,500 | |
Filed 2017-12-13 Tx date 2017-12-12 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-50,000
-100,000 vol $0.50 each |
1,436,500 | |
Filed 2017-12-13 Tx date 2017-12-12 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-48,000
-100,000 vol $0.48 each |
1,286,500 | |
Filed 2017-12-13 Tx date 2017-12-12 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-27,000
-50,000 vol $0.54 each |
1,386,500 | |
Filed 2017-09-12 Tx date 2016-11-02 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-09-12 Tx date 2017-09-10 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
Filed 2017-06-14 Tx date 2017-06-12 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$92,500
+500,000 vol $0.185 each |
1,536,500 | |
Filed 2017-04-17 Tx date 2017-04-13 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,315
-73,500 vol $0.29 each |
1,036,500 | |
Filed 2017-04-10 Tx date 2017-04-05 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$75,000
+500,000 vol $0.15 each |
1,110,000 | |
Filed 2017-03-31 Tx date 2017-03-30 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,550
-90,000 vol $0.195 each |
610,000 | |
Filed 2017-03-27 Tx date 2017-03-24 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$60,000
+500,000 vol $0.12 each |
700,000 | |
Filed 2017-01-27 Tx date 2016-11-02 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Warrants
99 - Correction of information
|
+200,000 vol |
400,000 | |
Filed 2017-01-27 Tx date 2017-01-18 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+200,000 vol |
200,000 | |
Filed 2017-01-27 Tx date 2017-01-18 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-14,000
-200,000 vol $0.07 each |
0 | |
Filed 2017-01-27 Tx date 2017-01-18 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$40,000,000,000
+200,000 vol $200,000 each |
200,000 | |
Filed 2017-01-18 Tx date 2017-01-09 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,000
-200,000 vol $0.14 each |
0 | |
Filed 2016-12-04 Tx date 2016-11-25 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,500
-100,000 vol $0.145 each |
200,000 | |
Filed 2016-11-17 Tx date 2016-11-15 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-14,000
-200,000 vol $0.07 each |
0 | |
Filed 2016-11-17 Tx date 2016-11-15 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$14,000
+200,000 vol $0.07 each |
300,000 | |
Filed 2016-11-17 Tx date 2016-11-14 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+100,000 vol |
100,000 | |
Filed 2016-11-17 Tx date 2016-11-02 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-11-07 Tx date 2016-11-02 |
$ATT
Abattis Bioceuticals Corp. |
Panenka, William
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
200,000 |